Parkinson?s Disease Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Parkinson?s Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Parkinson?s Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Parkinson?s Disease Treatment Overall Market Size
2.1 Global Parkinson?s Disease Treatment Market Size: 2021 VS 2028
2.2 Global Parkinson?s Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Parkinson?s Disease Treatment Players in Global Market
3.2 Top Global Parkinson?s Disease Treatment Companies Ranked by Revenue
3.3 Global Parkinson?s Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Parkinson?s Disease Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Parkinson?s Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Parkinson?s Disease Treatment Players in Global Market
3.6.1 List of Global Tier 1 Parkinson?s Disease Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Parkinson?s Disease Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Parkinson?s Disease Treatment Market Size Markets, 2021 & 2028
4.1.2 Oral
4.1.3 Transdermal
4.1.4 Subcutaneous
4.1.5 Intestinal Infusion
4.2 By Type - Global Parkinson?s Disease Treatment Revenue & Forecasts
4.2.1 By Type - Global Parkinson?s Disease Treatment Revenue, 2017-2022
4.2.2 By Type - Global Parkinson?s Disease Treatment Revenue, 2023-2028
4.2.3 By Type - Global Parkinson?s Disease Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Parkinson?s Disease Treatment Market Size, 2021 & 2028
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.2 By Application - Global Parkinson?s Disease Treatment Revenue & Forecasts
5.2.1 By Application - Global Parkinson?s Disease Treatment Revenue, 2017-2022
5.2.2 By Application - Global Parkinson?s Disease Treatment Revenue, 2023-2028
5.2.3 By Application - Global Parkinson?s Disease Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Parkinson?s Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Parkinson?s Disease Treatment Revenue & Forecasts
6.2.1 By Region - Global Parkinson?s Disease Treatment Revenue, 2017-2022
6.2.2 By Region - Global Parkinson?s Disease Treatment Revenue, 2023-2028
6.2.3 By Region - Global Parkinson?s Disease Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Parkinson?s Disease Treatment Revenue, 2017-2028
6.3.2 US Parkinson?s Disease Treatment Market Size, 2017-2028
6.3.3 Canada Parkinson?s Disease Treatment Market Size, 2017-2028
6.3.4 Mexico Parkinson?s Disease Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Parkinson?s Disease Treatment Revenue, 2017-2028
6.4.2 Germany Parkinson?s Disease Treatment Market Size, 2017-2028
6.4.3 France Parkinson?s Disease Treatment Market Size, 2017-2028
6.4.4 U.K. Parkinson?s Disease Treatment Market Size, 2017-2028
6.4.5 Italy Parkinson?s Disease Treatment Market Size, 2017-2028
6.4.6 Russia Parkinson?s Disease Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Parkinson?s Disease Treatment Market Size, 2017-2028
6.4.8 Benelux Parkinson?s Disease Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Parkinson?s Disease Treatment Revenue, 2017-2028
6.5.2 China Parkinson?s Disease Treatment Market Size, 2017-2028
6.5.3 Japan Parkinson?s Disease Treatment Market Size, 2017-2028
6.5.4 South Korea Parkinson?s Disease Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Parkinson?s Disease Treatment Market Size, 2017-2028
6.5.6 India Parkinson?s Disease Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Parkinson?s Disease Treatment Revenue, 2017-2028
6.6.2 Brazil Parkinson?s Disease Treatment Market Size, 2017-2028
6.6.3 Argentina Parkinson?s Disease Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Parkinson?s Disease Treatment Revenue, 2017-2028
6.7.2 Turkey Parkinson?s Disease Treatment Market Size, 2017-2028
6.7.3 Israel Parkinson?s Disease Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Parkinson?s Disease Treatment Market Size, 2017-2028
6.7.5 UAE Parkinson?s Disease Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Teva
7.1.1 Teva Corporate Summary
7.1.2 Teva Business Overview
7.1.3 Teva Parkinson?s Disease Treatment Major Product Offerings
7.1.4 Teva Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.1.5 Teva Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Parkinson?s Disease Treatment Major Product Offerings
7.2.4 Roche Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.2.5 Roche Key News
7.3 Prothena
7.3.1 Prothena Corporate Summary
7.3.2 Prothena Business Overview
7.3.3 Prothena Parkinson?s Disease Treatment Major Product Offerings
7.3.4 Prothena Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.3.5 Prothena Key News
7.4 Acorda Therapeutics
7.4.1 Acorda Therapeutics Corporate Summary
7.4.2 Acorda Therapeutics Business Overview
7.4.3 Acorda Therapeutics Parkinson?s Disease Treatment Major Product Offerings
7.4.4 Acorda Therapeutics Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.4.5 Acorda Therapeutics Key News
7.5 Voyager Therapeutics
7.5.1 Voyager Therapeutics Corporate Summary
7.5.2 Voyager Therapeutics Business Overview
7.5.3 Voyager Therapeutics Parkinson?s Disease Treatment Major Product Offerings
7.5.4 Voyager Therapeutics Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.5.5 Voyager Therapeutics Key News
7.6 Impax Pharmaceuticals
7.6.1 Impax Pharmaceuticals Corporate Summary
7.6.2 Impax Pharmaceuticals Business Overview
7.6.3 Impax Pharmaceuticals Parkinson?s Disease Treatment Major Product Offerings
7.6.4 Impax Pharmaceuticals Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.6.5 Impax Pharmaceuticals Key News
7.7 UCB
7.7.1 UCB Corporate Summary
7.7.2 UCB Business Overview
7.7.3 UCB Parkinson?s Disease Treatment Major Product Offerings
7.7.4 UCB Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.7.5 UCB Key News
7.8 AbbVie
7.8.1 AbbVie Corporate Summary
7.8.2 AbbVie Business Overview
7.8.3 AbbVie Parkinson?s Disease Treatment Major Product Offerings
7.8.4 AbbVie Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.8.5 AbbVie Key News
7.9 MSD
7.9.1 MSD Corporate Summary
7.9.2 MSD Business Overview
7.9.3 MSD Parkinson?s Disease Treatment Major Product Offerings
7.9.4 MSD Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.9.5 MSD Key News
7.10 Orion Pharmaceuticals
7.10.1 Orion Pharmaceuticals Corporate Summary
7.10.2 Orion Pharmaceuticals Business Overview
7.10.3 Orion Pharmaceuticals Parkinson?s Disease Treatment Major Product Offerings
7.10.4 Orion Pharmaceuticals Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.10.5 Orion Pharmaceuticals Key News
7.11 Intec Pharma
7.11.1 Intec Pharma Corporate Summary
7.11.2 Intec Pharma Business Overview
7.11.3 Intec Pharma Parkinson?s Disease Treatment Major Product Offerings
7.11.4 Intec Pharma Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.11.5 Intec Pharma Key News
7.12 NeuroDerm
7.12.1 NeuroDerm Corporate Summary
7.12.2 NeuroDerm Business Overview
7.12.3 NeuroDerm Parkinson?s Disease Treatment Major Product Offerings
7.12.4 NeuroDerm Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.12.5 NeuroDerm Key News
7.13 Adamas Therapeutics
7.13.1 Adamas Therapeutics Corporate Summary
7.13.2 Adamas Therapeutics Business Overview
7.13.3 Adamas Therapeutics Parkinson?s Disease Treatment Major Product Offerings
7.13.4 Adamas Therapeutics Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.13.5 Adamas Therapeutics Key News
7.14 Acadia
7.14.1 Acadia Corporate Summary
7.14.2 Acadia Business Overview
7.14.3 Acadia Parkinson?s Disease Treatment Major Product Offerings
7.14.4 Acadia Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.14.5 Acadia Key News
7.15 Sunovion
7.15.1 Sunovion Corporate Summary
7.15.2 Sunovion Business Overview
7.15.3 Sunovion Parkinson?s Disease Treatment Major Product Offerings
7.15.4 Sunovion Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.15.5 Sunovion Key News
7.16 GSK
7.16.1 GSK Corporate Summary
7.16.2 GSK Business Overview
7.16.3 GSK Parkinson?s Disease Treatment Major Product Offerings
7.16.4 GSK Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.16.5 GSK Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Parkinson?s Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Parkinson?s Disease Treatment Market Drivers in Global Market
Table 3. Parkinson?s Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Parkinson?s Disease Treatment in Global Market
Table 5. Top Parkinson?s Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Parkinson?s Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Parkinson?s Disease Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Parkinson?s Disease Treatment Product Type
Table 9. List of Global Tier 1 Parkinson?s Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Parkinson?s Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Parkinson?s Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Parkinson?s Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Parkinson?s Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Parkinson?s Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Parkinson?s Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Parkinson?s Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Parkinson?s Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Parkinson?s Disease Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Parkinson?s Disease Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Parkinson?s Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Parkinson?s Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Parkinson?s Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Parkinson?s Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Parkinson?s Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Teva Corporate Summary
Table 31. Teva Parkinson?s Disease Treatment Product Offerings
Table 32. Teva Parkinson?s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche Parkinson?s Disease Treatment Product Offerings
Table 35. Roche Parkinson?s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Prothena Corporate Summary
Table 37. Prothena Parkinson?s Disease Treatment Product Offerings
Table 38. Prothena Parkinson?s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Acorda Therapeutics Corporate Summary
Table 40. Acorda Therapeutics Parkinson?s Disease Treatment Product Offerings
Table 41. Acorda Therapeutics Parkinson?s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Voyager Therapeutics Corporate Summary
Table 43. Voyager Therapeutics Parkinson?s Disease Treatment Product Offerings
Table 44. Voyager Therapeutics Parkinson?s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Impax Pharmaceuticals Corporate Summary
Table 46. Impax Pharmaceuticals Parkinson?s Disease Treatment Product Offerings
Table 47. Impax Pharmaceuticals Parkinson?s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 48. UCB Corporate Summary
Table 49. UCB Parkinson?s Disease Treatment Product Offerings
Table 50. UCB Parkinson?s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 51. AbbVie Corporate Summary
Table 52. AbbVie Parkinson?s Disease Treatment Product Offerings
Table 53. AbbVie Parkinson?s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 54. MSD Corporate Summary
Table 55. MSD Parkinson?s Disease Treatment Product Offerings
Table 56. MSD Parkinson?s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Orion Pharmaceuticals Corporate Summary
Table 58. Orion Pharmaceuticals Parkinson?s Disease Treatment Product Offerings
Table 59. Orion Pharmaceuticals Parkinson?s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Intec Pharma Corporate Summary
Table 61. Intec Pharma Parkinson?s Disease Treatment Product Offerings
Table 62. Intec Pharma Parkinson?s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 63. NeuroDerm Corporate Summary
Table 64. NeuroDerm Parkinson?s Disease Treatment Product Offerings
Table 65. NeuroDerm Parkinson?s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Adamas Therapeutics Corporate Summary
Table 67. Adamas Therapeutics Parkinson?s Disease Treatment Product Offerings
Table 68. Adamas Therapeutics Parkinson?s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Acadia Corporate Summary
Table 70. Acadia Parkinson?s Disease Treatment Product Offerings
Table 71. Acadia Parkinson?s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Sunovion Corporate Summary
Table 73. Sunovion Parkinson?s Disease Treatment Product Offerings
Table 74. Sunovion Parkinson?s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 75. GSK Corporate Summary
Table 76. GSK Parkinson?s Disease Treatment Product Offerings
Table 77. GSK Parkinson?s Disease Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Parkinson?s Disease Treatment Segment by Type in 2021
Figure 2. Parkinson?s Disease Treatment Segment by Application in 2021
Figure 3. Global Parkinson?s Disease Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Parkinson?s Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Parkinson?s Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Parkinson?s Disease Treatment Revenue in 2021
Figure 8. By Type - Global Parkinson?s Disease Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Parkinson?s Disease Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Parkinson?s Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Parkinson?s Disease Treatment Revenue Market Share, 2017-2028
Figure 12. US Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Parkinson?s Disease Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Parkinson?s Disease Treatment Revenue Market Share, 2017-2028
Figure 24. China Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Parkinson?s Disease Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Parkinson?s Disease Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Parkinson?s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Teva Parkinson?s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Parkinson?s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Prothena Parkinson?s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Acorda Therapeutics Parkinson?s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Voyager Therapeutics Parkinson?s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Impax Pharmaceuticals Parkinson?s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. UCB Parkinson?s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AbbVie Parkinson?s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. MSD Parkinson?s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Orion Pharmaceuticals Parkinson?s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Intec Pharma Parkinson?s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. NeuroDerm Parkinson?s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Adamas Therapeutics Parkinson?s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Acadia Parkinson?s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Sunovion Parkinson?s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. GSK Parkinson?s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
